FDA Warns Companies To Stop Selling Kratom As Cure For Opioid Addiction
The FDA is cracking down on the sale of Kratom
The Food and Drug Administration issued warning letters Tuesday to two private companies for illegally selling unapproved, misbranded drugs containing kratom and claiming that their products can cure opioid addiction and withdrawal symptoms.
Cali Botanicals, based in Folsom, California, and Kratom NC, of Wilmington, North Carolina, also claim that their products can treat pain and cancer, as well as mental health conditions such as depression and anxiety.
“We have issued numerous warnings about the serious risks associated with the use of kratom, including warnings about the contamination of kratom products with high rates of salmonella that put people using kratom products at risk, and resulted in numerous illnesses and recalls,” the acting FDA commissioner, Dr. Ned Sharpless, said in a statement. “Despite our warnings, companies continue to sell this dangerous product and make deceptive medical claims that are not backed by science or any reliable scientific evidence.”
To Read The Rest Of This Article On NBC News, Click Here
